DAWN
Price
$7.21
Change
+$0.22 (+3.15%)
Updated
Sep 18 closing price
Capitalization
738.53M
52 days until earnings call
JAZZ
Price
$131.19
Change
+$1.65 (+1.27%)
Updated
Sep 18 closing price
Capitalization
7.95B
47 days until earnings call
Interact to see
Advertisement

DAWN vs JAZZ

Header iconDAWN vs JAZZ Comparison
Open Charts DAWN vs JAZZBanner chart's image
Day One Biopharmaceuticals
Price$7.21
Change+$0.22 (+3.15%)
Volume$823.15K
Capitalization738.53M
Jazz Pharmaceuticals
Price$131.19
Change+$1.65 (+1.27%)
Volume$860.08K
Capitalization7.95B
DAWN vs JAZZ Comparison Chart in %
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. JAZZ commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and JAZZ is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 19, 2025
Stock price -- (DAWN: $7.21 vs. JAZZ: $131.11)
Brand notoriety: DAWN and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 53% vs. JAZZ: 115%
Market capitalization -- DAWN: $738.53M vs. JAZZ: $7.95B
DAWN [@Biotechnology] is valued at $738.53M. JAZZ’s [@Biotechnology] market capitalization is $7.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 6 TA indicator(s) are bullish while JAZZ’s TA Score has 5 bullish TA indicator(s).

  • DAWN’s TA Score: 6 bullish, 4 bearish.
  • JAZZ’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both DAWN and JAZZ are a good buy in the short-term.

Price Growth

DAWN (@Biotechnology) experienced а -2.17% price change this week, while JAZZ (@Biotechnology) price change was +2.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +38.54%.

Reported Earning Dates

DAWN is expected to report earnings on Nov 10, 2025.

JAZZ is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($7.95B) has a higher market cap than DAWN($739M). JAZZ YTD gains are higher at: 6.464 vs. DAWN (-43.094). JAZZ has higher annual earnings (EBITDA): 372M vs. DAWN (-108.37M). JAZZ has more cash in the bank: 1.67B vs. DAWN (453M). DAWN has less debt than JAZZ: DAWN (3M) vs JAZZ (5.43B). JAZZ has higher revenues than DAWN: JAZZ (4.09B) vs DAWN (188M).
DAWNJAZZDAWN / JAZZ
Capitalization739M7.95B9%
EBITDA-108.37M372M-29%
Gain YTD-43.0946.464-667%
P/E RatioN/A15.38-
Revenue188M4.09B5%
Total Cash453M1.67B27%
Total Debt3M5.43B0%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNJAZZ
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
60%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 23 days ago
80%
Bullish Trend 1 day ago
59%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDTX26.030.41
+1.60%
Artisan Focus Fund Advisor
AFICX93.150.62
+0.67%
American Funds Fundamental Invs C
ACGLX23.30N/A
N/A
Invesco Growth and Income R
HEOMX18.27N/A
N/A
Hartford Climate Opportunities A
CCGSX27.33N/A
N/A
Baird Chautauqua Global Growth Inv